Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

RecruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Rabies ExposureImmunocompromisedChronic Disease
Interventions
OTHER

Observation Only

All participants will receive post-exposure rabies vaccination using either the Zagreb or Essen regimen, in accordance with national immunization guidelines.

Trial Locations (1)

Unknown

RECRUITING

Luohu District People's Hospital., Shenzhen

All Listed Sponsors
collaborator

Shenzhen Center for Disease Control and Prevention

OTHER_GOV

lead

Liaoning Chengda Biotechnology CO., LTD

INDUSTRY